Summary
Albert Kooistra is a translational bioinformatics entrepreneur and scientist with over nine years of experience in structural bioinformatics, cheminformatics, and data-driven drug discovery. He is currently Co-Founder and CSO of Synamics Therapeutics, shaping scientific strategy and cutting-edge computational R&D at the intersection of academia and biotech. He previously served as Co-Founder & CTO of Synamics Therapeutics and is an Associate Professor at the University of Copenhagen, actively bridging research and commercialization. As head of the KLIFS structural kinase database and former lead developer of GPCRdb, he has built and steered cornerstone resources that power modern drug discovery. Based in Copenhagen, he earned a PhD in Computational Medicinal Chemistry from VU Amsterdam and an MSc in Bioinformatics, reflecting a strong blend of theory, tool-building, and practical application.
9 years of coding experience
17 years of employment as a software developer
Vrije Universiteit Amsterdam